ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $65,960 | -45.9% | 17,000 | -66.0% | 0.01% | -53.8% |
| Q3 2022 | $122,000 | -22.8% | 50,000 | -37.5% | 0.01% | 0.0% |
| Q2 2022 | $158,000 | -42.5% | 80,000 | -46.7% | 0.01% | -56.7% |
| Q1 2022 | $275,000 | +29.7% | 150,000 | 0.0% | 0.03% | +30.4% |
| Q4 2021 | $212,000 | -9.0% | 150,000 | -27.2% | 0.02% | -20.7% |
| Q3 2021 | $233,000 | -11.1% | 206,000 | +25.6% | 0.03% | -12.1% |
| Q2 2021 | $262,000 | +48.9% | 164,000 | +64.0% | 0.03% | +26.9% |
| Q1 2021 | $176,000 | -9.7% | 100,000 | 0.0% | 0.03% | -16.1% |
| Q4 2020 | $195,000 | +36.4% | 100,000 | +66.7% | 0.03% | -11.4% |
| Q3 2020 | $143,000 | +146.6% | 60,000 | +200.0% | 0.04% | +84.2% |
| Q2 2020 | $58,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |